Zobrazeno 1 - 10
of 127
pro vyhledávání: '"T. E Morozova"'
Autor:
T. E Morozova, O. A Vartanova
Publikováno v:
КардиоСоматика, Vol 4, Iss 1, Pp 28-35 (2013)
Statins, the most common drugs to lower lipid levels, are «strategic» products for the treatment of patients with coronary heart disease (CHD), atherosclerosis, having the ability to reduce the cardiovascular and total mortality. This class of drug
Externí odkaz:
https://doaj.org/article/2c37262e54934044bc80c0737e8ff005
Publikováno v:
Сеченовский вестник, Vol 0, Iss 2, Pp 56-63 (2022)
Aim. Optimization of pharmacotherapy of patients with metabolic syndrome and chronic kidney disease according to the nephroprotective properties of antihypertensive drugs.Methods. 81 patients (38 male, 43 female, age 29-79 years, mean age 53,4± 11,6
Externí odkaz:
https://doaj.org/article/65265a0e22fb41d895051492ad9b7c77
Publikováno v:
Сеченовский вестник, Vol 0, Iss 4, Pp 48-53 (2022)
The article deals with the problems of drug therapy of patients with coronary heart disease combined with chronic obstructive pulmonary disease taking beta-blockers.
Externí odkaz:
https://doaj.org/article/f48933bd3e634951a1d10dd5df70b441
Autor:
E. N. Tkhoseva, T. E. Morozova, O. A. Vartanova, S. M. Rykova, T. B. Andruschishina, D. A. Ermakov, S. M. Oshorova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 4, Pp 29-36 (2022)
In article results pharmacoepidemiology researches on studying of knowledge of pharmacists (n=187) on safety issues medicinal and pharmacovigilance are resulted. 28 % of pharmacists have adverse drug reactions to medicines in the practice, however su
Externí odkaz:
https://doaj.org/article/5a4022ecbd854e22871d0ae4895e1ea5
Autor:
T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Z. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. А. Grishina, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 719-723 (2021)
Aim. Evaluation of the effect of polymorphisms of the CYP2D6, CYP2C8 genes on the efficacy and safety of postoperative analgesia with ketoprofen in patients with coronary artery disease after cardiac surgery.Material and methods. The study included 9
Externí odkaz:
https://doaj.org/article/315eddefede3447a9f0ce3236f933058
Autor:
T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Zh. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. A. Grishina, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 4, Pp 570-575 (2021)
Aim. The aim of the study was to evaluate the efficacy and safety of ketoprofen as an analgesic therapy in patients with CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910 gene polymorphisms after cardiac surgery.Material and methods. The st
Externí odkaz:
https://doaj.org/article/544a1dde8efd4fd1af17a485b0e980f3
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 42-50 (2021)
One-third of patients attending a general practitioner’s office have some type of medical problem associated with pain. The most common types of acute pain in patients who consult a general practitioner are musculoskeletal pain in the neck and lowe
Externí odkaz:
https://doaj.org/article/46930ab55989494ba7ba7feb2180bbe6
Publikováno v:
Сеченовский вестник, Vol 11, Iss 4, Pp 50-59 (2020)
Aim. To develop a visual aid “Comorbid patient Scale” and evaluate its effectiveness through dynamic follow-up of patients with chronic non-communicable diseases (NCDs) in outpatient practice.Materials and methods. The prevalence of risk factors
Externí odkaz:
https://doaj.org/article/b25f4c5b0704451185c220af3e52e9b6
Autor:
K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 5, Pp 670-677 (2020)
Aim. To search for new pharmacogenetic biomarkers of bleeding risk in patients taking rivaroxaban and dabigatran for different indications: atrial fibrillation, endoprosthesis of large joints of lower limbs.Material and methods. The study enrolled 29
Externí odkaz:
https://doaj.org/article/060e30356f7741b38e1ef181c3cd5e48
Publikováno v:
Антибиотики и Химиотерапия, Vol 63, Iss 9-10, Pp 39-47 (2020)
Objective. To evaluate the effectiveness, rationality, and safety of the use of antibacterial medications for the purpose of perioperative prophylaxis (POP) of infectious complications in patients of surgical departments in a multidisciplinary hospit
Externí odkaz:
https://doaj.org/article/1ea3ad20134b4ca9adbe4e38e0c42cec